Amanda Pires Bonfanti

Dr. Amanda Pires Bonfanti

Immunology, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LVLiana Verinaud
Liana Verinaud
SLStefanie COSTA PINTO Lopes
Stefanie COSTA PINTO Lopes
IPIsabel Cristina Naranjo Prado
Isabel Cristina Naranjo Prado
FZFábio Zanucoli
Fábio Zanucoli
TCThiago Alves da Costa
Thiago Alves da Costa
RTRodolfo Thome
Rodolfo Thome
Inflammation is a necessary process to control infection. However, exacerbated inflammation, acute or chronic, promotes deleterious effects in the organism. Violacein (viola), a quorum sensing metabolite from the Gram-negative bacterium Chromobacterium violaceum, has been shown to protect mice from malaria and to have beneficial effects on tumors. However, it is not known whether this drug possesses anti-inflammatory activity. In this study, we investigated whether viola administration is able to reduce acute and chronic autoimmune inflammation. For that purpose, C57BL/6 mice were intraperitoneally injected with 1 μg of LPS and were treated with viola (3.5mg/kg) via i.p. at the same time-point. Three hours later, the levels of inflammatory cytokines in the sera and phenotypical characterization of leukocytes were determined. Mice treated with viola presented a significant reduction in the production of inflammatory cytokines compared with untreated mice. Interestingly, although viola is a compound derived from bacteria, it did not induce inflammation upon administration to naïve mice. To test whether viola would protect mice from an autoimmune inflammation, Experimental Autoimmune Encephalomyelitis (EAE)-inflicted mice were given viola i.p. at disease onset, at the 10th day from immunization. Viola-treated mice developed mild EAE disease in contrast with placebo-treated mice. The frequencies of dendritic cells and macrophages were unaltered in EAE mice treated with viola. However, the sole administration of viola augmented the levels of splenic regulatory T cells (CD4+Foxp3+). We also found that adoptive transfer of viola-elicited regulatory T cells significantly reduced EAE. Our study shows, for the first time, that violacein is able to modulate acute and chronic inflammation. Amelioration relied in suppression of cytokine production (in acute inflammation) and stimulation of regulatory T cells (in chronic inflammation). New studies must be conducted in order to assess the possible use of viola in therapeutic approaches in human autoimmune diseases.

1 July 2020 in Brain Research Bulletin
Verified
Journal Article
Closed access
ABANDRE BOMBEIRO
ANDRE BOMBEIRO
BPBruna Toledo Nunes Pereira
Bruna Toledo Nunes Pereira
Amanda Pires BonfantiAmanda Pires Bonfanti
Amanda Pires Bonfanti
Alexandre OliveiraAlexandre Oliveira
Alexandre Oliveira

1 August 2018 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
EDEduardo Duarte-Silva
Eduardo Duarte-Silva
SAShyrlene Meiry da Rocha Araújo
Shyrlene Meiry da Rocha Araújo
WOWilma Helena Oliveira
Wilma Helena Oliveira
DLDeniele Bezerra de Lós
Deniele Bezerra de Lós
MFMaria Eduarda Rocha de França
Maria Eduarda Rocha de França
CPChristina Alves Peixoto
Christina Alves Peixoto

13 October 2014 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
LVLiana Verinaud
Liana Verinaud
LILuidy Kazuo Issayama
Luidy Kazuo Issayama
FZFábio Zanucoli
Fábio Zanucoli
ACAna Carolina de Carvalho
Ana Carolina de Carvalho
TCThiago Alves da Costa
Thiago Alves da Costa
RTRodolfo Thome
Rodolfo Thome

1 May 2020 in Molecular Immunology
Verified
Journal Article
Closed access
ABANDRE BOMBEIRO
ANDRE BOMBEIRO
BLBruno Henrique de Melo Lima
Bruno Henrique de Melo Lima
Amanda Pires BonfantiAmanda Pires Bonfanti
Amanda Pires Bonfanti
Alexandre OliveiraAlexandre Oliveira
Alexandre Oliveira

3 November 2025 in Cancer Research
Verified
Journal Article
Closed access
PSPratima Saini
Pratima Saini
GMGauri Mirji
Gauri Mirji
S M Shamsul Islam, PhDS M Shamsul Islam, PhD
S M Shamsul Islam, PhD
LSLacy M Simons
Lacy M Simons
SBSajad Ahmad Bhat
Sajad Ahmad Bhat
MAMohamed Abdel-Mohsen
Mohamed Abdel-Mohsen
Tumor-associated macrophages (TAM) in the pancreatic ductal adenocarcinoma (PDAC) tumor microenvironment (TME) exhibit immunosuppressive phenotypes and impaired phagocytic activity, facilitating tumor progression and immune evasion. In this study, we identified integrin α3β1, composed of ITGA3 and ITGB1 subunits, as a sialylated glycoprotein ligand for Siglec-10, an inhibitory glyco-immune checkpoint receptor highly expressed on TAMs in PDAC. The interaction between Siglec-10 on TAMs and α3β1 on PDAC cells suppressed macrophage-mediated phagocytosis, thereby promoting immune evasion. Consistently, disrupting Siglec-10 interactions using mAbs significantly enhanced macrophage phagocytosis of PDAC cells and alleviated myeloid cell–mediated inhibition of T-cell proliferation and activation in vitro. In both a xenograft mouse model engrafted with human macrophages and a human Siglec-10 transgenic mouse model, targeting Siglec-10 with mAbs reduced PDAC growth. These findings suggest that Siglec-10 interactions are key mediators of TAM-driven immune evasion in PDAC and highlight the therapeutic potential of targeting these interactions to restore antitumor immunity. Significance: Pancreatic tumor cells exploit integrin α3β1 to engage the immunosuppressive checkpoint receptor Siglec-10 on myeloid cells, driving immune evasion, which can be targeted with antibody-mediated blockade of Siglec-10 to restore antitumor immunity.